IRhythm Technologies Operating Income 2015-2024 | IRTC

IRhythm Technologies operating income from 2015 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
IRhythm Technologies Annual Operating Income
(Millions of US $)
2023 $-125
2022 $-114
2021 $-100
2020 $-44
2019 $-55
2018 $-46
2017 $-28
2016 $-16
2015 $-22
2014 $-15
IRhythm Technologies Quarterly Operating Income
(Millions of US $)
2024-09-30 $-50
2024-06-30 $-23
2024-03-31 $-38
2023-12-31 $-39
2023-09-30 $-28
2023-06-30 $-19
2023-03-31 $-40
2022-12-31 $-21
2022-09-30 $-21
2022-06-30 $-23
2022-03-31 $-49
2021-12-31 $-32
2021-09-30 $-23
2021-06-30 $-17
2021-03-31 $-27
2020-12-31 $-10
2020-09-30 $-5
2020-06-30 $-20
2020-03-31 $-9
2019-12-31 $-18
2019-09-30 $-18
2019-06-30 $-11
2019-03-31 $-8
2018-12-31 $-14
2018-09-30 $-9
2018-06-30 $-12
2018-03-31 $-11
2017-12-31 $-11
2017-09-30 $-6
2017-06-30 $-6
2017-03-31 $-5
2016-12-31 $-4
2016-09-30 $-3
2016-06-30 $-4
2016-03-31 $-5
2015-12-31
2015-09-30 $-6
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.799B $0.493B
iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Hims & Hers Health (HIMS) United States $5.506B 140.00
Tempus AI (TEM) United States $5.393B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00